Effect of azasterols on sterol metabolism in the laying hen

Studies on the effect of feeding cupric sulfate pentahydrate to laying hens on egg cholesterol content

Two experiments were conducted to test the hypothesis that pharmacological levels of dietary Cu could reduce egg cholesterol content. White Leghorn hens 30 to 39 wk of age were fed corn and soybean meal diets with 0, 125, or 250 mg supplemental Cu/kg diet from cupric sulfate pentahydrate (basal diet = 6.74 mg Cu/kg). Body weight, feed consumption, egg weights, egg specific gravity, and Haugh Units were not consistently affected during the 8-wk feeding trials. Egg production was significantly increased (P < 0.05) in the second 4-wk period by supplemental Cu in both experiments. Egg yolk cholesterol concentrations were decreased by feeding 125 mg Cu/kg diet (11.7 vs 8.6 mg/g, average of two experiments); feeding 250 mg Cu/kg resulted in further declines in egg cholesterol but the differences were not significant (7.9 mg/g). Changes in plasma cholesterol concentrations were similar to those of yolk cholesterol. Small but significant amounts of Cu accumulated in the yolks and shells of eggs from Cu-supplemented hens; however, most of the Cu fed was found in the excreta.

Effect of dietary 7-ketocholesterol, pure, or oxidized cholesterol on hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity, energy balance, egg cholesterol concentration, and 14C-acetate incorporation into yolk lipids of laying hens

Experiments were conducted to study the effect of 7-ketocholesterol (7-k) in the presence or absence of pure cholesterol (PCH) or oxidized cholesterol (OCH) in diets of laying hens on reproductive performance and several parameters of cholesterol metabolism. In the first experiment, cholesterol synthesis and transport was examined by the in ovo incorporation of 14C-acetate into yolk triglycerides and cholesterol. Energy balances were also conducted. In the second experiment, hepatic 3 hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity was measured in vitro to evaluate potential cholesterol synthesis. In both experiments, reproductive performance and egg yolk cholesterol concentration were measured. Dietary PCH or OCH (.5%) significantly reduced relative acetate incorporation into yolk cholesterol, while 7-k (.025%) had no effect on carbon flow from acetate into egg cholesterol. While 7-k alone did not alter total yolk cholesterol concentration, it moderated the effect of PCH or OCH on increasing yolk cholesterol concentration. No consistent effects of dietary sterols on reproductive performance or energy balance were observed. Hepatic HMG CoA reductase activity was dramatically suppressed by feeding PCH or OCH and moderately suppressed by 7-k. In combination with PCH or OCH, 7-k did not further depress enzyme activity. The observations that 7-k alone depressed hepatic HMG-CoA reductase activity, without changing relative acetate incorporation into yolk cholesterol while limiting cholesterol deposition in egg yolk from PCH or OCH, is interpreted to mean that 7-k may stimulate sterol transport and excretion while limiting cholesterol synthesis.

Changes in the lipid metabolism of the chick embryo with parental age

A study has been made on the distribution and composition of the lipids associated with the yolk contents, yolk sac membrane, liver, and extrahepatic tissues of chick embryos at Days 15 and 19 of incubation from 25- and 41-week-old broiler-breeder stock. The higher embryo mortality displayed by the eggs from the young breeders was associated with an abnormal distribution of lipid between the tissue pools. The amount of lipid associated with the total yolk, i.e., yolk contents plus yolk sac membrane, of the embryos from the 25-week-old parents at Day 19 of incubation was greater than that of the embryos from the 41-week-old parents, and there was a much higher proportion of lipid still remaining in association with the yolk contents. In the embryos from the young parents, a smaller proportion of embryonic lipid was associated with the extra-hepatic tissues at Day 19 of incubation. Differences were observed in the relative proportions of the major lipid fractions within the yolk and embryonic tissues between the eggs from the two sets of parents. The higher mortality of the embryos from the young parents was associated with a malfunction of yolk lipid assimilation and mobilization from the yolk contents thereby denying access to the major nutrient associated with development during the last week of incubation.

Effect of cholesterol oxidation products on cholesterol metabolism in the laying hen

Two experiments were conducted to determine the effect of purified cholesterol and oxidized cholesterol in the diet of the laying hen on egg production characteristics, in vitro - in ovo utilization of acetate for cholesterol biosynthesis, and the activity of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in biosynthesis of cholesterol. Previous work has demonstrated inhibition of cholesterol synthesis by cholesterol oxides in tissue culture cells but not in hepatic tissues of animals through dietary administration. Feeding .5% of either purified or oxidized cholesterol had no effect on egg production, egg weight, body weight, or diet consumption. In both experiments egg yolk cholesterol was significantly increased by both cholesterol sources, but eggs from hens fed oxidized cholesterol had lower cholesterol contents than those from hens fed purified cholesterol. Relative utilization of acetate for cholesterol biosynthesis was significantly reduced by feeding both cholesterol sources. Hepatic enzyme activity measured by production of mevalonic acid was significantly inhibited by feeding purified cholesterol. A further significant reduction in enzyme activity was observed when oxidized cholesterol was fed, indicating that dietary cholesterol oxides are much more potent than purified cholesterol in limiting the activity of the enzyme.

Effect of probucol on reproductive performance, egg yolk cholesterol content, and lipid metabolism in the laying hen

Egg production type chickens were given the drug Probucol in their diets to determine its effect on egg production characteristics, liver lipid metabolism, egg yolk lipid synthesis, and egg yolk cholesterol concentration. In none of the three trials conducted did Probucol feeding affect egg production or body weight. The drug reduced total liver lipogenesis as measured by incorporation of 14C-acetate by surviving liver slices. Relative incorporation of 14C-acetate into cholesterol by liver was increased by the drug. However, in ovo incorporation of 14C-acetate in total yolk lipids remains unchanged and relative incorporation into yolk cholesterol is reduced. As a result, egg yolk cholesterol content is reduced by 5% with the .10% dietary level of drug administration.

Effects of branched and straight chain amines and azasteroids on blood and egg cholesterol of White Leghorn chickens

Six branched and straight chain secondary or tertiary amines with chain lengths of 12 to 18 carbons and two azasteroids, 25-aza-5 alpha-cholestane and 25-azacoprostane, were fed to mature White Leghorn hens, and their effectiveness was compared with 20,25-diazacholesterol dihydrochloride (SC-12937), an azasteroid known to lower egg cholesterol. Feed consumption, body weight, egg production, egg and plasma cholesterol and desmosterol, and plasma total lipid were measured. The 6 amines were fed at 200 ppm, and only the C12 branched chain amine N,N,3,711-pentamethyldodecanamine reduced plasma and egg cholesterol with a concomitant increase in desmosterol. After 4 weeks, plasma desmosterol was 0, 13, 60, and 75% of total sterol for control, 200 ppm C12 branched chain amine, 5 ppm diazacholesterol, and 5 ppm azacholestane, respectively. Egg production was severely reduced to 6 and 0% by feeding 5 ppm azacholestane for 2 and 4 weeks, respectively, and to 69 and 36% by feeding 5 ppm diazacholesterol. After 4 weeks egg cholesterol was 79 and 36% of the total sterol for the 200 ppm C12 branched chain amine and 5 ppm diazacholesterol, respectively. Concomitant increases in desmosterol accompanied all reductions in cholesterol. The depletion and repletion rates of egg cholesterol were measured in a subsequent experiment. After 2-1/2 weeks of feeding the test substances, egg cholesterol was reduced with concomitant increases in desmosterol. Egg cholesterol was 100, 71, and 50% of the total egg sterol for control, 200 ppm, and 400 ppm C12 branched chain amine, respectively: 58, 13, and 3% for .1, .5, and 1.0 ppm azacholestane; 28, 29, and 18% for 1, 2.5, and 5 ppm azacholesterol; and 23% for 1 ppm azacoprostane. The experimental diets were then withdrawn, and egg cholesterol repletion was studied biweekly. Egg cholesterol was repleted to 100% of the total sterol after withdrawal times of 2 weeks for C12 branched chain amine, 8 weeks for azacoprpostane, 14 to 16 weeks for diazacholesterol, 10 to 16 weeks for the lower levels of azacholestane, and longer than 16 weeks for 1 ppm azacholestane. The increase in desmosterol accompaning the demonstrated reduction in egg cholesterol, particularly with azasteroids, causes one to question the usefulness of this approach to lower cholesterol.

Effect of 3-hydroxy-3-methylglutaric acid on cholesterol metabolism in female Japanese quail

The compounds 3-hydroxy-3-methylglutaric acid (HMG) and HMG diethylester were administered to laying Coturnix hens to evaluate their potential in reducing yolk cholesterol concentrations. The administration of HMG did not produce consistent differences from controls in tissue levels of either cholesterol or triglycerides. The administration of HMG diethylester appeared to increase the de novo synthesis of cholesterol and the mobilization of cholesterol from liver to serum, as assayed by the uptake and conversion of [1-14C]acetate into 14C-cholesterol. Neither HMG diethylester nor HMG significantly decreased the amount of cholesterol deposited in egg yolk.

Effects of diazacholesterol, triparanol, and beta-sitosterol on egg cholesterol deposition in coturnix quail

Studies were undertaken to determine the effect of inhibitors of cholesterol synthesis on deposition of cholesterol in eggs of Japanese quail. Results indicate that this bird responds similarly to the laying hen, making it a useful screening device for these types of compounds. Administration of either triparanol or 20,25 diazacholesterol resulted in a decreased cholesterol content of the yolk. Concomitant with this decrease was an increase in desmosterol deposition. Beta sitosterol (2%) fed either alone or with lecithin (2%) did not result in a decrease in egg yolk cholesterol. No beta-sitosterol was found in the egg yolk. Diazacholesterol fed either with sitosterol, or sitosterol plus lecithin, was not effective in reducing the total sterol content of egg.

A nutrient re-evaluation of shell eggs

Most data on the nutrient composition of shell eggs were obtained before 1950. Since then, management systems for egg production and analytical methods for many components have changed. Freeze-dried whole egg, yolk and white samples were prepared from eggs obtained from a single source of 15 month old White Leghorns. The sample were packaged under nitrogen and held at -20 degrees C. until analyzed. Conversion factors are included for expressing the amount of each component on a per egg as well as a per 100 g. edible liquid basis. This re-evaluation of nutrient data included total solids, lipid, protein, cholesterol, ash, calories, amino acids, fatty acids, vitamins and minerals.

Homoazasterol-mediated inhibition of yeast sterol biosynthesis

A naturally occurring azasterol has been shown to inhibit sterol transmethylation in both in vitro and in vivo in the yeast Saccharomyces cerevisiae. The inhibition was competitive, with a calculated dissociation constant of 43 muM. The compound prevented the accumulation of ergosterol in aerobically adapting cells. Cultures forced to gain energy by respiration were found to be much more sensitive to growth inhibition by the azasterol than those cells fermenting glucose. The growth inhibition is reversible at low concentrations of the azasterol.

Structure-function activity of azasterols and nitrogen-containing steroids

Thirty-nine nitrogen-containing steroids were tested against two gram-negative, five gram-positive, and two yeast organisms. Many of these steroids have been previously reported to inhibit various metabolic processes involving sterol metabolism. While low minimal inhibitory concentration (MIC) values were recorded for sterol producing yeast, growth of bacteria which contain no sterols was also inhibited. Structure-function studies provided no relationship between biological activity and hypocholesteremic effects of these azasteroids. A hypothesis put forward is that amino and azasteroids are effectors of membrane which, in the case of mitochondria, lead to changes in adenosine triphosphate levels and/or dehydrogenase activity. Their effects on sterol metabolism, therefore, may be of secondary consideration.

The cholesterol problem, the egg and lipid metabolism in the laying hen

There is little doubt that high blood serum lipid levels are related to a higher incidence of atherosclerotic disease in humans. Experimental evidence to date suggests that dietary intervention can reduce blood lipid levels in most cases and that some small reduction in occurrence of cardiovascular disease will probably result. On the other hand no reduction in total mortality has been demonstrated in the well constructed dietary studies. It appears that there is considerable variation in the human population with regard to their patterns of lipid metabolism. Some apparently regulate body production of cholesterol in response to dietary changes, others do not. Some seem to excrete excess sterols efficiently, while some do not. It seems likely, therefore, that dietary manipulation would be useful for those disposed by heredity and other conditions to accumulation of excessive sterols in the body. On the other hand drug control of cholesterol biosynthesis and/or sterol excretion may be more effective solutions to the problem of sterol accumulation. Irrespective of whether diet or drugs prove to be the best answer to control of sterol balance, these should be applied only to that segment of the population known to require such treatment. The egg is an important dietary source of cholesterol and as a result is used sparingly in low cholesterol diets. On the other hand normal egg consumption of two eggs per day does not appear to overload cholesterol balance in the healthy human adult since depression in cholesterol biosynthesis and increased sterol excretion will result. Investigation of the lipid metabolism of the laying hen has shown that most of the cholesterol found in the egg is synthesized in the liver where it is under both dietary and drug control. Most of the cholesterol deposited in egg yolk may be essential for embryonic development. Drugs that severely limit cholesterol biosynthesis probably also limit synthesis of adrenal and sex hormones and hence limit reproduction. Moderate depressions in lipogenesis achieved without feeding of large amounts of dietary fat may offer a means for moderating cholesterol deposition in eggs. On the other hand, it also seems clear that genetic selection could be used to moderate egg cholesterol concentration. In any event, a great deal more evidence from well constructed human diet studies will be needed before low cholesterol diets can be recommended to the general population as an aid to control of cholesterol balance and heart disease.